Synopsis
Synopsis
0
JDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anxut
2. Apo Buspirone
3. Apo-buspirone
4. Bespar
5. Busp
6. Buspar
7. Buspirone
8. Gen Buspirone
9. Gen-buspirone
10. Hydrochloride, Buspirone
11. Lin Buspirone
12. Lin-buspirone
13. Mj 9022 1
14. Mj-9022-1
15. Mj90221
16. N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
17. Neurosine
18. Novo Buspirone
19. Novo-buspirone
20. Nu Buspirone
21. Nu-buspirone
22. Pms Buspirone
23. Pms-buspirone
24. Ratio Buspirone
25. Ratio-buspirone
1. 33386-08-2
2. Buspar
3. Buspirone Hcl
4. Narol
5. Buspimen
6. Buspirone (hydrochloride)
7. Mj 9022-1
8. 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
9. Nsc-751138
10. Nsc-759571
11. Mj-9022-1
12. Mls000069796
13. N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide Monohydrochloride
14. 207lt9j9oc
15. Apd405
16. Chebi:3224
17. Apd-405
18. Ansitec
19. Anxinil
20. Anxiolan
21. Busirone
22. Buspinol
23. Censpar
24. Effiplen
25. Establix
26. Kallmiren
27. Lucelan
28. Mabuson
29. Normaton
30. Smr000058186
31. Spamilan
32. Barpil
33. Bespar
34. Itagil
35. Nerbet
36. Sburol
37. Travin
38. Tutran
39. Biron
40. Relac
41. 33386-08-2 (hcl)
42. Apo-buspirone
43. 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
44. 8-azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, Monohydrochloride
45. 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
46. 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
47. Buspirone Hydrochloride [usan]
48. Sr-01000075541
49. Einecs 251-489-4
50. Unii-207lt9j9oc
51. C21h31n5o2.hcl
52. Prestwick_711
53. Buspirone Hydrochloride [usan:usp]
54. Buspar (tn)
55. Mfcd00078569
56. Opera_id_707
57. 1,1-cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, Hydrochloride
58. 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione Hydrochloride
59. Schembl41495
60. Mls001076085
61. Mls002548862
62. Buspirone Hydrochloride (usp)
63. Buspirone Hydrochloride Solution
64. Buspirone For System Suitability
65. Chembl1200399
66. Dtxsid1037193
67. Hms1569i19
68. Hms3750o03
69. Pharmakon1600-02300173
70. Apc-6002
71. Apc-6003
72. Bcp28463
73. Hy-b1115
74. Buspirone Hydrochloride [mi]
75. Tox21_500223
76. Buspirone Hydrochloride [jan]
77. Nsc751138
78. Nsc759571
79. S4256
80. Akos015962019
81. Ac-1905
82. Buspirone Hydrochloride [mart.]
83. Buspirone Hydrochloride [vandf]
84. Ccg-213652
85. Cs-4714
86. H05b847
87. Ks-5163
88. Lp00223
89. Nc00673
90. Nsc 751138
91. Nsc 759571
92. Buspirone Hydrochloride [usp-rs]
93. Buspirone Hydrochloride [who-dd]
94. Ncgc00093692-01
95. Ncgc00093692-02
96. Ncgc00260908-01
97. 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione Monohydrochloride
98. Buspirone Hydrochloride [orange Book]
99. Eu-0100223
100. Sw155073-5
101. Buspirone Hydrochloride [ep Monograph]
102. B 7148
103. Buspirone Hydrochloride [usp Monograph]
104. D00702
105. D96810
106. Q-200768
107. Sr-01000075541-1
108. Sr-01000075541-3
109. Sr-01000075541-7
110. Q27105997
111. Buspirone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
112. Buspirone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
113. Buspirone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
114. 8-azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, Monohydrochloride
115. Buspirone For System Suitability, European Pharmacopoeia (ep) Reference Standard
116. Buspirone Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
117. 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium Chloride
118. 8-[4-[4-(2-pyrimidinyl)-1-pipirazin Yl]butyl]-8-azaspiro[4,5]decane-7,9-dione Hydrochloride
119. 8-[4-[4-(2-pyrimidinyl)-1-pipirazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione Hydrochloride
120. 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione Hydrochloride
121. 8-azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, Hydrochloride (1:1)
122. Buspirone Hcl Pound>>mj 9022 1 Pound>> Mj-9022-1 Pound>>mj90221 Pound>>mj9022 1 Pound>>mj9022-1
123. Buspirone Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 422.0 g/mol |
|---|---|
| Molecular Formula | C21H32ClN5O2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 421.2244530 g/mol |
| Monoisotopic Mass | 421.2244530 g/mol |
| Topological Polar Surface Area | 69.6 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 529 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Buspirone hydrochloride |
| Drug Label | Buspirone hydrochloride tablets USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.Buspirone hydrochloride is a white crystalline, water soluble co... |
| Active Ingredient | Buspirone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
| Market Status | Prescription |
| Company | Watson Labs; Teva; Zydus Pharms Usa; Strides Arcolab; Dr Reddys Labs; Prosam Labs; Mylan |
| 2 of 2 | |
|---|---|
| Drug Name | Buspirone hydrochloride |
| Drug Label | Buspirone hydrochloride tablets USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.Buspirone hydrochloride is a white crystalline, water soluble co... |
| Active Ingredient | Buspirone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
| Market Status | Prescription |
| Company | Watson Labs; Teva; Zydus Pharms Usa; Strides Arcolab; Dr Reddys Labs; Prosam Labs; Mylan |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Granulation
Disintegrants & Superdisintegrants
Lubricants & Glidants
Thickeners and Stabilizers
Co-Processed Excipients
Controlled & Modified Release
Solubilizers
Coating Systems & Additives
Taste Masking
Emulsifying Agents
Parenteral
Chewable & Orodispersible Aids
Film Formers & Plasticizers
Surfactant & Foaming Agents
Topical
Rheology Modifiers
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Buspirone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buspirone Hydrochloride, including repackagers and relabelers. The FDA regulates Buspirone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buspirone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Buspirone Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Buspirone Hydrochloride supplier is an individual or a company that provides Buspirone Hydrochloride active pharmaceutical ingredient (API) or Buspirone Hydrochloride finished formulations upon request. The Buspirone Hydrochloride suppliers may include Buspirone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Buspirone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Buspirone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Buspirone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Buspirone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Buspirone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Buspirone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Buspirone Hydrochloride USDMF includes data on Buspirone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Buspirone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Buspirone Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Buspirone Hydrochloride Drug Master File in Korea (Buspirone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Buspirone Hydrochloride. The MFDS reviews the Buspirone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Buspirone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Buspirone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Buspirone Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Buspirone Hydrochloride suppliers with KDMF on PharmaCompass.
A Buspirone Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Buspirone Hydrochloride Certificate of Suitability (COS). The purpose of a Buspirone Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Buspirone Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Buspirone Hydrochloride to their clients by showing that a Buspirone Hydrochloride CEP has been issued for it. The manufacturer submits a Buspirone Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Buspirone Hydrochloride CEP holder for the record. Additionally, the data presented in the Buspirone Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Buspirone Hydrochloride DMF.
A Buspirone Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Buspirone Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Buspirone Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Buspirone Hydrochloride written confirmation (Buspirone Hydrochloride WC) is an official document issued by a regulatory agency to a Buspirone Hydrochloride manufacturer, verifying that the manufacturing facility of a Buspirone Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Buspirone Hydrochloride APIs or Buspirone Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Buspirone Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Buspirone Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Buspirone Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Buspirone Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Buspirone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Buspirone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Buspirone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Buspirone Hydrochloride suppliers with NDC on PharmaCompass.
Buspirone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Buspirone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buspirone Hydrochloride GMP manufacturer or Buspirone Hydrochloride GMP API supplier for your needs.
A Buspirone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Buspirone Hydrochloride's compliance with Buspirone Hydrochloride specifications and serves as a tool for batch-level quality control.
Buspirone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Buspirone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Buspirone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Buspirone Hydrochloride EP), Buspirone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buspirone Hydrochloride USP).
LOOKING FOR A SUPPLIER?
